Skip to main content
. 2022 Dec 10;15:170. doi: 10.1186/s13045-022-01379-0

Fig. 2.

Fig. 2

Subgroup analysis of OS at 24 months in phase 2 treated patients (N = 55). aNumber of subjects at risk at Month 24. bAssessed after bridging therapy and prior to KTE-X19 infusion. CNS = central nervous system. LCI = lower confidence interval. OS = overall survival; SCT = stem cell transplant. UCI = upper confidence interval